Search

Prestige Consumer Healthcare

Open

SectorGezondheidszorg

48.95 -0.65

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

48.28

Max

49.58

Belangrijke statistieken

By Trading Economics

Inkomsten

7.2M

54M

Verkoop

-1.8M

282M

K/W

Sectorgemiddelde

12.54

62.58

EPS

1.23

Winstmarge

19.149

Werknemers

890

EBITDA

4.5M

85M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+46.88% upside

Dividenden

By Acuity

Volgende Winsten

6 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-8.7M

2.4B

Vorige openingsprijs

49.6

Vorige sluitingsprijs

48.95

Nieuwssentiment

By Acuity

50%

50%

144 / 340 Rangschikking in Healthcare

Prestige Consumer Healthcare Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 jul 2026, 21:11 UTC

In after-market trading, Prestige Consumer Healthcare Inc is higher, reaching its highest cumulative return of the day and remaining above its 20-day moving average.

21 jul 2026, 15:41 UTC

Prestige Consumer Healthcare Inc shares are lower today, diverging from broader market strength as no specific news was identified to explain the decline.

20 jul 2026, 19:52 UTC

Prestige Consumer Healthcare Inc. is trading higher today, recovering from earlier lows. The stock remains near the upper end of its one-month range.

Peer Vergelijking

Prijswijziging

Prestige Consumer Healthcare Prognose

Koersdoel

By TipRanks

46.88% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 72 USD  46.88%

Hoogste 72 USD

Laagste 72 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Prestige Consumer Healthcare - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Sentiment

By Acuity

144 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat